Drug · DIN 02230384
LERITONE JUNIOR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 21, 1999; first marketed March 30, 1998.
- Drug Identification Number (DIN)
- 02230384
- Company (DIN owner)
- Institut De Recherche Biologique Yves Ponroy Canada Inc.Lachine, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Capsule
- Route
- Oral
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VITAMIN B12 (VITAMIN B12) | 0.24 MCG | CAP |
| VITAMIN E (D-ALPHA TOCOPHERYL ACID SUCCINATE) | 4 UNIT | CAP |
Other DINs named LERITONE JUNIOR
- DIN 02237106 · Cancelled Post Market